{"id":"https://openalex.org/W3193043005","doi":null,"title":"Randomized trial of resistance testing for virologic failure in Sub-Saharan Africa","display_name":"Randomized trial of resistance testing for virologic failure in Sub-Saharan Africa","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3193043005","mag":"3193043005"},"language":"en","primary_location":{"id":"pmh:oai:research-repository.griffith.edu.au:10072/406414","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10072/406414","pdf_url":null,"source":{"id":"https://openalex.org/S7407064376","display_name":"Griffith Research Online","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Conference output"},"volume":null,"type":"conference-paper","indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10072/406414","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003051495","display_name":"Mark Jacob Siedner","orcid":"https://orcid.org/0000-0003-3506-842X","observed_orcids":["https://orcid.org/0000-0003-3506-842X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. Siedner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035982137","display_name":"Mahomed\u2010Yunus S. Moosa","orcid":"https://orcid.org/0000-0001-6191-4023","observed_orcids":["https://orcid.org/0000-0001-6191-4023"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahomed\u2010Yunus S. Moosa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6191-4023","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042882515","display_name":"Suzanne M. McCluskey","orcid":"https://orcid.org/0000-0001-8463-5430","observed_orcids":["https://orcid.org/0000-0001-8463-5430"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne M. McCluskey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8463-5430","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013586561","display_name":"Kevin L. Ard","orcid":"https://orcid.org/0000-0003-2421-4559","observed_orcids":["https://orcid.org/0000-0003-2421-4559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin L. Ard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2421-4559","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065154623","display_name":"Winnie R. Muyindike","orcid":"https://orcid.org/0000-0002-6694-2645","observed_orcids":["https://orcid.org/0000-0002-6694-2645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Winnie Muyindike","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6694-2645","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030189452","display_name":"Pravi Moodley","orcid":"https://orcid.org/0000-0002-9946-8783","observed_orcids":["https://orcid.org/0000-0002-9946-8783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pravi Moodley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9946-8783","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051615343","display_name":"Jaysingh Brijkumar","orcid":"https://orcid.org/0000-0002-3511-2112","observed_orcids":["https://orcid.org/0000-0002-3511-2112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaysingh Brijkumar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3511-2112","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077298777","display_name":"Tamlyn Anne Rautenberg","orcid":"https://orcid.org/0000-0002-3912-3740","observed_orcids":["https://orcid.org/0000-0002-3912-3740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamlyn Rautenberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3912-3740","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005725328","display_name":"Gavin George","orcid":"https://orcid.org/0000-0001-7258-8470","observed_orcids":["https://orcid.org/0000-0001-7258-8470"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin George","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7258-8470","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084610327","display_name":"Rajesh Ghandi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh Ghandi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062529721","display_name":"Brent A. Johnson","orcid":"https://orcid.org/0000-0001-5665-8598","observed_orcids":["https://orcid.org/0000-0001-5665-8598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brent A. Johnson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5665-8598","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075398862","display_name":"Henry Sunpath","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Sunpath","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110028284","display_name":"Mwebesa Bwana","orcid":"https://orcid.org/0000-0002-9189-3937","observed_orcids":["https://orcid.org/0000-0002-9189-3937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mwebesa Bwana","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9189-3937","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075575064","display_name":"Vincent C. Marconi","orcid":"https://orcid.org/0000-0001-8409-4689","observed_orcids":["https://orcid.org/0000-0001-8409-4689"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent C. Marconi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8409-4689","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20330033,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.03530000150203705,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/genotypic-resistance-testing","display_name":"genotypic resistance testing","score":0.8930000066757202},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.8410000205039978},{"id":"https://openalex.org/keywords/first-line-antiretroviral-therapy","display_name":"first-line antiretroviral therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9319999814033508},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.7889999747276306},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.42399999499320984},{"id":"https://openalex.org/keywords/retention-in-care","display_name":"retention in care","score":0.7599999904632568},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.574999988079071},{"id":"https://openalex.org/keywords/sub-saharan-africa","display_name":"sub-Saharan Africa","score":0.6290000081062317},{"id":"https://openalex.org/keywords/south-africa","display_name":"South Africa","score":0.4790000021457672},{"id":"https://openalex.org/keywords/uganda","display_name":"Uganda","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adherence-counseling","display_name":"adherence counseling","score":0.5090000033378601},{"id":"https://openalex.org/keywords/viral-load-monitoring","display_name":"viral load monitoring","score":0.6460000276565552},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.5730000138282776},{"id":"https://openalex.org/keywords/resource-limited-settings","display_name":"resource-limited settings","score":0.6940000057220459},{"id":"https://openalex.org/keywords/treatment-intensification","display_name":"treatment intensification","score":0.3400000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7998995780944824},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5742101073265076},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5614773631095886},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.5407095551490784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5167955160140991},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.50348299741745},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.44254544377326965},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.43918377161026},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18549203872680664}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:research-repository.griffith.edu.au:10072/406414","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10072/406414","pdf_url":null,"source":{"id":"https://openalex.org/S7407064376","display_name":"Griffith Research Online","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Conference output"},{"id":"mag:3193043005","doi":null,"is_oa":false,"landing_page_url":"https://research-repository.griffith.edu.au/handle/10072/406414","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:research-repository.griffith.edu.au:10072/406414","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10072/406414","pdf_url":null,"source":{"id":"https://openalex.org/S7407064376","display_name":"Griffith Research Online","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Conference output"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6000000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3208085339","https://openalex.org/W3214616060","https://openalex.org/W2002929277","https://openalex.org/W2979948820","https://openalex.org/W4413311851","https://openalex.org/W4401931029","https://openalex.org/W3186414291","https://openalex.org/W1983797872","https://openalex.org/W1905569384","https://openalex.org/W2417019307"],"abstract_inverted_index":{"Genotypic":[0],"resistance":[1,167,260,329],"testing":[2],"(GRT)":[3],"is":[4],"recommended":[5],"after":[6,47,131,318],"virologic":[7,23,45,102,314],"failure":[8,52,321,341],"in":[9,15,25,53,59,62,118,160,209,212,238,250,278,299,330,358],"resource-rich":[10],"settings.":[11],"By":[12],"contrast,":[13],"guidelines":[14],"sub-Saharan":[16,54,300],"Africa":[17,64],"promote":[18],"adherence":[19,99],"support":[20],"and":[21,65,101,163,185,199,214,344],"repeat":[22],"monitoring,":[24],"the":[26,210,251,302,325,359],"absence":[27],"of":[28,126,165,304,313,327,339,346],"GRT,":[29,109],"to":[30,40,95,104,257,306,349,355],"guide":[31],"treatment.":[32],"We":[33,56,78,177],"conducted":[34],"an":[35,71],"open-label,":[36],"randomized":[37,93],"controlled":[38],"trial":[39],"assess":[41],"whether":[42],"GRT":[43,119,305],"improved":[44],"suppression":[46,150,154,315],"first-line":[48,68,157,319],"antiretroviral":[49],"therapy":[50,357],"(ART)":[51],"Africa.":[55],"enrolled":[57,178],"adults":[58],"ambulatory":[60],"care":[61,143,213,308],"South":[63],"Uganda":[66],"on":[67],"ART":[69,194,320,340],"with":[70,86,98,110,173,243,332],"HIV-1":[72],"RNA":[73],"viral":[74],"load":[75],"(VL)>1,000":[76],"copies/mL.":[77,176],"excluded":[79],"those":[80,138,172,331],"currently":[81],"eligible":[82],"for":[83],"second-line":[84],"or":[85,107,140,292],"prior":[87],"known":[88],"drug":[89,166,259,328],"resistance.":[90],"Individuals":[91],"were":[92,134,144,201,236,254],"1:1":[94],"standard-of-care":[96],"(SOC),":[97],"counseling":[100],"monitoring":[103],"determine":[105],"management,":[106],"immediate":[108],"therapeutic":[111],"decision":[112],"making":[113],"by":[114,183,222],"clinic":[115],"staff":[116],"trained":[117],"interpretation.":[120],"The":[121,187],"primary":[122],"outcome":[123],"was":[124,190,196,206],"achievement":[125,312],"VL<200":[127,217],"copies/mL":[128,218,246],"9":[129,220,248,316],"months":[130,221,249,317],"enrollment.":[132],"Analyses":[133],"intent-to-treat":[135],"such":[136],"that":[137,336],"deceased":[139],"lost":[141],"from":[142,353],"considered":[145],"failures.":[146],"Secondary":[147],"outcomes":[148],"included":[149],"less":[151],"than":[152],"assay,":[153],"while":[155],"maintaining":[156],"ART,":[158],"retention":[159],"care,":[161],"mortality,":[162],"presence":[164],"at":[168,219,247],"study":[169],"conclusion":[170],"among":[171],"a":[174,216,244],"VL>1,000":[175,245],"840":[179],"participants,":[180],"divided":[181],"equally":[182],"country":[184],"sex.":[186],"median":[188,193],"age":[189],"37":[191],"years,":[192,198],"duration":[195],"3":[197],"82%":[200],"taking":[202],"efavirenz-based":[203,354],"ART.":[204],"There":[205],"no":[207,276],"difference":[208,277],"proportion":[211],"achieving":[215],"arm":[223,253],"(SOC:":[224,262,281],"256/423,":[225],"61%;":[226],"RT:":[227],"263/417,":[228],"63%,":[229],"OR":[230,268,287],"1.11,":[231],"95%CI":[232,270],"0.83-1.49,":[233],"P=0.46).":[234],"Results":[235],"similar":[237],"pre-defined":[239],"sub-groups":[240],"(Figure).":[241],"Those":[242],"SOC":[252],"more":[255],"likely":[256],"have":[258],"detected":[261],"75/103":[263],"75%;":[264],"GRT:":[265,284],"46/82":[266],"56%,":[267],"2.39,":[269],"1.28-4.48,":[271],"P=0.01),":[272],"but":[273,322],"we":[274],"found":[275],"9-month":[279],"mortality":[280],"8/423,":[282],"2%;":[283],"14/417":[285],"4%,":[286],"0.55,":[288],"95%":[289],"0.23-1.33,":[290],"P=0.19)":[291],"other":[293],"secondary":[294],"outcomes.":[295],"In":[296],"public":[297],"clinics":[298],"Africa,":[301],"addition":[303],"routine":[307],"did":[309,323],"not":[310],"improve":[311,337],"lower":[324],"likelihood":[326],"persistent":[333],"viremia.":[334],"Interventions":[335],"management":[338],"remain":[342],"elusive":[343],"are":[345],"particular":[347],"importance":[348],"enable":[350],"prompt":[351],"transition":[352],"dolutegravir-based":[356],"region.":[360]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2021-08-16T00:00:00"}